1 week RT

RADIATION2 trials

Sponsors

Tata Medical Center, Post Graduate Institute of Medical Education and Research, Chandigarh

Conditions

Breast CancerBreast Cancer FemaleHypofractionationRadiotherapy Side Effect

Unknown Phase

One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer

RecruitingNCT03788213

Tata Medical CenterBreast Cancer Female

Start: 2019-03-26End: 2029-03-26Target: 2100Updated: 2024-10-23

HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).

RecruitingNCT04472845

Post Graduate Institute of Medical Education and Research, ChandigarhBreast Cancer, Hypofractionation, Radiotherapy Side Effect

Start: 2021-03-30End: 2028-08-20Target: 1018Updated: 2022-12-08

Related Papers

HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-Risk Patients With Breast Cancer (HYPART): Acute Toxicity Results.

2025-08-06

One-week regimen for postoperative regional irradiation in breast cancer: the ARROW trial protocol

BMJ Open2025-05-01

HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.

2024-01-027 citations

Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial

BMJ Open2022-09-0115 citations

Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.

2020-09-3016 citations